Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Motor Activity 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma 11Lymphoma, Follicular 5Leukemia 5Leukemia, Lymphocytic, Chronic, B-Cell 4Breast Neoplasms 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Obesity 2Neoplasms 2Hodgkin Disease 2Fatigue 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Ventricular Dysfunction, Left 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcopenia 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Parasomnias 1Overweight 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1

Interventions

Ursodeoxycholic Acid 1Exercise 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-alcoholic Fatty Liver Disease × Exercise × Lymphoid × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡